share_log

中基長壽科學：截至二零二四年三月三十一日止股份發行人的證券變動月報表

ZHONG JI LS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

HKEX ·  Apr 2 14:55
Summary by Futu AI
中基長壽科學（00767）於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本結存維持在400,000,000港元，每股面值0.01港元，總股份數目為40,000,000,000股，本月無增減變動。已發行股份亦保持在455,441,291股，無新增或減少。此外，根據2012年採納的購股權計劃，公司於2020年底授出的股份期權數目為3,868,000股，本月無變動，而可換股票據的未行使總額為2,182,400,000港元，亦無本月變動。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
中基長壽科學（00767）於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本結存維持在400,000,000港元，每股面值0.01港元，總股份數目為40,000,000,000股，本月無增減變動。已發行股份亦保持在455,441,291股，無新增或減少。此外，根據2012年採納的購股權計劃，公司於2020年底授出的股份期權數目為3,868,000股，本月無變動，而可換股票據的未行使總額為2,182,400,000港元，亦無本月變動。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
China Foundation Longevity Sciences (00767) filed with Hong Kong Trading and Settlement Limited on 2 April 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in company shares for the year ended 31 March 2024. The report showed that the company's regulated/registered share capital was maintained at HK$400,000,000 with a face value of HK$0.01 per share, with a total number of shares of 40,000,000,000 shares, unchanged this month. The issued shares also remained at 455,441,291 shares, with no additions or decreases. In addition, under the Share Option Plan adopted in 2012, the number of share options granted by the Company at the end of 2020 was 3,868,000 shares, unchanged for the month, and the total outstanding amount of convertible notes was HK$2,182,400,000, unchanged for the month. The Company confirms that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
China Foundation Longevity Sciences (00767) filed with Hong Kong Trading and Settlement Limited on 2 April 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in company shares for the year ended 31 March 2024. The report showed that the company's regulated/registered share capital was maintained at HK$400,000,000 with a face value of HK$0.01 per share, with a total number of shares of 40,000,000,000 shares, unchanged this month. The issued shares also remained at 455,441,291 shares, with no additions or decreases. In addition, under the Share Option Plan adopted in 2012, the number of share options granted by the Company at the end of 2020 was 3,868,000 shares, unchanged for the month, and the total outstanding amount of convertible notes was HK$2,182,400,000, unchanged for the month. The Company confirms that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.